Vodafone Idea, Adani Total Gas, HDFC Bank, Hind Rectifiers and more: Top stocks to watch on September 23
SUMMARY
From SpiceJet, HFCL to Glenmark Pharma and Aarti Drugs, here are the top stocks to look out for on Monday, September 23.
By Asmita Pant September 23, 2024, 12:29:29 AM IST (Updated)
Vodafone Idea | The debt-ridden telecom operator concludes a mega $3.6 billion or ₹30,000 crore deal with Nokia, Ericsson and Samsung, for the supply of network equipment over a period of three years. This marks the first step towards the company’s transformative three-year capex plan of $6.6 billion (₹55,000 crore).
Adani Total Gas | The city gas joint venture between Adani Group and TotalEnergies of France secures a financing package of $375 million from global lenders. This financing marks the largest global funding initiative in the CGD (city gas distribution) business.
SpiceJet | The airline’s board approves the issuance and allotment of 48.7 crore equity shares to qualified institutional buyers at ₹61.60 per share, including a premium of ₹51.60 and a discount of ₹3.19 per share to the floor price. The total amount raised from the issue will be ₹2,999.99 crore.
Mankind Pharma | The pharma company board approves raising of up to ₹10,000 crore through the issuance of non-convertible debentures (NCDs) and commercial papers (CPs) via private placement.
Reliance Industries | The company extends the deadline for paying call money on partly paid shares to October 7, 2024. Shareholders who fail to pay the call money by this date will be ineligible for the bonus issue.
HFCL | The teleco signs a strategic partnership with General Atomics Aeronautical Systems Incorporated (GA-ASI). Under the agreement, the company has been selected to develop and supply critical sub-systems for GA-ASI’s advanced Unmanned Aircraft Systems (UAS).
BHEL | The PSU receives a notification of an award worth ₹6,100 crore from NTPC for an 800 MW thermal power project.
Hind Rectifiers | The electrical and electronic equipment manufacturer bags order worth more than ₹200 crore from the Indian railways.
HDFC Bank | The lender’s subsidiary, HDB Financial Service, is planning an initial public offering comprising a fresh issue of up to ₹2,500 crore and an offer for sale by existing and eligible shareholders.
Aarti Drugs | The USFDA issues a Form 483 with seven observations for its API manufacturing unit in Tarapur. None of the observations relate to data integrity. The unit was inspected between September 12-20, 2024.
Glenmark Pharmaceuticals | The drug firm announces the completion of a routine US Food and Drug Administration inspection at the formulation manufacturing facility in Chhatrapati Sambhaji Nagar (Aurangabad) with zero observations.